share_log

Needham Reiterates Buy on Ionis Pharmaceuticals, Maintains $60 Price Target

Needham Reiterates Buy on Ionis Pharmaceuticals, Maintains $60 Price Target

Needham 重申买入 Ionis Pharmicals,维持60美元的目标价格
Moomoo 24/7 ·  04/09 06:34

Needham analyst Joseph Stringer reiterates Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and maintains $60 price target.

Needham分析师约瑟夫·斯金格重申爱奥尼斯制药(纳斯达克股票代码:IONS)的买入,并维持60美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发